Category: ARCS

APT, ARCS, Software Release

I’m APT to be a little excited over version 4.0

The holidays came almost two months early for users of ACUTA PDF Tools (APT) as version 4 was released on October 31, 2017. With the new release, APT continues to evolve to work with new guidance, as well as features that improve publishing processes for Bio/Pharma companies using it to assemble their submission-ready documents. A key …

ACUTA, ARCS, ARIM, eCTD, FDA

Six Months until Mandatory eCTD for INDs, DMFs at FDA

Almost seven months ago, I posted my first ACUTA blog entry on the FDA requirement for eCTD for all marketing applications, a little under a month before the May 5, 2017 deadline. The sky didn’t fall, companies didn’t fold for being unable to comply… and ARCS (ACUTA Clinical & Regulatory Services) helped numerous companies achieve …

ACUTA, ARCS, ARIM, Australia, eCTD, NeES

E-Submissions Looking Up Down Under

Australia’s Therapeutic Goods Administration (TGA) released updated guidance for both eCTD (electronic Common Technical Document) and NeES (Non-eCTD Electronic Submissions). Version 3.1 of the Australian regional eCTD specifications, and version 2.0 of the NeES specifications will be accepted starting January 1, 2018, and will be mandatory July 1, 2018. Because the eCTD and NeES are …

ARCS, ARIM Publisher, eCTD, eCTD 4, FDA

eCTD – It’s not just a good idea, it’s the law

Joel Finkle, Director Regulatory Innovation & IDMP Strategy Note: This post appeared previously on LinkedIn.com Some of you have been following my writing for a few years; I’ve got a new home at Acuta. For others, this may be the first you’ve seen of my posts. I’ve been involved with electronic regulatory submissions since 1991 …